From: MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells
miRNA family | miRNA | Chrom’l location | Expression | Selected target mRNAs2 | Functions3 |
---|---|---|---|---|---|
let-7 | let-7 g-5p | 3p21.1 | Up-reg’d | IGF1R* | Angiogenesis, apoptosis |
 |  |  |  | MYC* | Angiogenesis, apoptosis, cancer, Jak-STAT, MAPK & Wnt signaling |
 | let-7 g-3p |  | Up-reg’d | ZEB1 | EMT, transcriptional misregulation in cancer |
 |  |  |  | NLK | Angiogenesis, MAPK & Wnt signaling |
 | let-7d-5p | 9q22.32 | Up-reg’d | IGF1R* | Angiogenesis, apoptosis |
 |  |  |  | THBS1* | Angiogenesis, cell cycle, p53 signaling, cancer |
 | let-7d-3p |  | Down-reg’d | KRAS | Apoptosis, MAPK & VEGF signaling, cancer |
 |  |  |  | PRKACB | Apoptosis, MAPK, Wnt & Hedgehog signaling |
 | let-7i-5p | 12q14.1 | Up-reg’d | TLR4* | Toll-like receptor signaling, inflammatory response |
 |  |  |  | IL13* | Cell-cell signaling, Jak-STAT, Toll-like receptor signaling, cytokine-cytokine receptor interaction |
 | let-7i-3p |  | Up-reg’d | DLX5 | Cell proliferation |
 |  |  |  | ACTB | Focal adhesion, leukocyte transendothelial migration |
mir-8/200 | miR-200a-5p | 1p36.33 | Up-reg’d | ZEB2 | EMT, Wnt signaling |
 |  |  |  | FGF4 | Apoptosis, MAPK signaling |
 | miR-200a-3p |  | Up-reg’d | ZEB1* | EMT, transcriptional misregulation in cancer |
 |  |  |  | ZEB2* | EMT, Wnt signaling |
 | miR-200b-5p | 1p36.33 | Down-reg’d | ZEB2 | EMT, Wnt signaling |
 |  |  |  | PRDM6 | Chromatin modification |
 | miR-200b-3p |  | Up-reg’d | ZEB1* | EMT, transcriptional misregulation in cancer |
 |  |  |  | MLH1 | Mismatch repair, cancer |
 | miR-141-5p | 12p13.31 | Up-reg’d | ATM | Apoptosis, cell cycle, p53 signaling, cancer |
 |  |  |  | CLDN1 | Cell adhesion, leukocyte transendothelial migration |
 | miR-141-3p |  | Up-reg’d | MYC* | Angiogenesis, apoptosis, cancer, Jak-Stat, MAPK & Wnt signaling |
 |  |  |  | TP53* | Angiogenesis, apoptosis, cell cycle, MAPK, p53 & Wnt signaling, cancer |
mir-17 | miR-17-5p | 13q31.3 | Up-reg’d | THBS1* | Angiogenesis, cell cycle, p53 signaling, cancer |
 |  |  |  | E2F1* | Apoptosis, cell cycle, cancer |
 | miR-17-3p |  | Up-reg’d | CD44 | Angiogenesis, inflammation, cancer |
 |  |  |  | MYB | Cancer |
 | miR-18a-5p | 13q31.3 | Up-reg’d | THBS1* | Angiogenesis, cell cycle, p53 signaling, cancer |
 |  |  |  | HIF1A* | Angiogenesis, cell migration, VEGF signaling |
 | miR-18a-3p |  | Up-reg’d | KRAS* | Apoptosis, MAPK & VEGF signaling, cancer |
 |  |  |  | CASP7 | Apoptosis |
 | miR-20a-5p | 13q31.3 | Up-reg’d | THBS1* | Angiogenesis, cell cycle, p53 signaling, cancer |
 |  |  |  | E2F1* | Apoptosis, cell cycle, cancer |
 | miR-20a-3p |  | Up-reg’d | KRAS | Apoptosis, MAPK & VEGF signaling, cancer |
 |  |  |  | PCNA | Cell cycle, cancer |